Skip to contentL
Lexicon Pharmaceuticals, Inc.
L
LXRXLexicon Pharmaceuticals, Inc. Q1 2021 · 10-Q
Revenue$0.00$0.00no prior Q1 2020 on file Net Income-$20.96M-$20.96Mno prior Q1 2020 on file EPS, diluted—
Operating Income-$20,839,000— Operating Cash Flow-$25,159,000—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
Free Cash Flowderived-$25,197,000— ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end